Activating Compound | Comment | Organism | Structure |
---|---|---|---|
polyinosinic-polycytidylic acid | treatment with 15-30 mg/kg polyinosinic-polycytidylic acid results in villous atrophy and activation of TG2 at the villus tips in small intestine | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ERW1041E | - |
Mus musculus |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Ca2+ | dependent on | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
duodenum | - |
Mus musculus | - |
ileum | - |
Mus musculus | - |
jejunum | - |
Mus musculus | - |
small intestine | enzyme activity is most pronounced in the duodenum, and decreased progressively in the jejunum and ileum | Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
TG2 | - |
Mus musculus |
tissue transglutaminase | - |
Mus musculus |
transglutaminase 2 | - |
Mus musculus |